-
1 Comment
Vireo Health International, Inc is currently in a long term uptrend where the price is trading 15.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.3.
Vireo Health International, Inc's total revenue rose by 32.8% to $12M since the same quarter in the previous year.
Its net income has increased by 100.3% to $122K since the same quarter in the previous year.
Finally, its free cash flow fell by 28.2% to $-9M since the same quarter in the previous year.
Based on the above factors, Vireo Health International, Inc gets an overall score of 4/5.
ISIN | None |
---|---|
Industry | Drug Manufacturers-Specialty & Generic |
Sector | Healthcare |
CurrencyCode | EUR |
Exchange | F |
Target Price | None |
---|---|
PE Ratio | None |
Market Cap | 253M |
Beta | 1.89 |
Dividend Yield | None |
Vireo Health International Inc. operates as a physician-led cannabis company in the United States. It cultivates cannabis; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other retail locations, and third-party dispensaries. The company grows and/or processes cannabis in eight markets and operates 16 dispensaries. Vireo Health International Inc. is headquartered in Minneapolis, Minnesota.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0ZF1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024